Creatinine Measurement - Global Market Outlook (2017-2026)

According to , the Global Creatinine Measurement Market is accounted for $330.90 million in 2017 and is expected to reach $745.00 million by 2026 growing at a CAGR of 9.4% during the forecast period. The growing renal functioning disorder and increasing geriatric population are driving the market. However, often changing regulatory policies and recognition of novel renal dysfunction biomarkers are hampering the market growth. Moreover, commercialization of sophisticated testing methods is providing ample opportunity for the growth of the market.

Creatinine measurement is the process of measuring creatinine. Creatinine is a waste product that is obtained from the human body due to the general breakdown of muscle tissues. The creatinine produced in the body is then filtered using kidneys. The basic kidney test carried out is analyzed using the creatinine levels in the blood.

Based on the sample, blood/ serum segment is attributed to observe ample growth opportunities, as most of the creatinine measurement kits and reagents are based on the analysis of creatinine in blood samples due to its accurateness in inferring creatinine concentration and less menace of contamination. These benefits are liable for the growing acceptance of the blood/serum sample for the measurement of creatinine levels.

By geography, North America acquired largest market share owing to the factors such as rising occurrence of renal disorders, increasing the prevalence of other chronic disorders like hypertension and diabetes (which can lead to renal dysfunction) in the region and the implementation of favorable management initiatives to raise awareness about kidney diseases and their untimely diagnosis.

Some of the key players profiled in the Creatinine Measurement market include Siemens Healthineers, Abbott Laboratories (US), Diazyme Laboratories, Inc., Wako Pure Chemical Industries Ltd., Randox Laboratories, Danaher Corporation (US), Pointe Scientific, Thermo Fisher Scientific Inc, Ortho-Clinical Diagnostics, F. Hoffmann-la Roche Ltd (Switzerland), Roche, Dialab GmbH (Vienna), Sentinel Ch. Spa. (Italy) and Diasys Diagnostic Systems GmbH (Germany).

Types Covered:
• Jaffe’S Kinetic Method
• Enzymatic Method

Products Covered:
• Kits
• Reagents

Samples Covered:
• Blood/Serum
• Urine

End Users Covered:
• Diagnostic Laboratories
• Hospitals

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Frequently Asked Questions